Literature DB >> 18991659

Vascular endothelial growth factor in central nervous system injuries - a vascular growth factor getting nervous?

Mattias K Sköld1, Martin Kanje.   

Abstract

Vascular Endothelial Growth Factor (VEGF) is recognized as a central factor in growth, survival and permeability of blood vessels in both physiological and pathological conditions. It is as such of importance for vascular responses in various central nervous system (CNS) disorders. Accumulating evidence suggest that VEGF may also act as a neuroprotective and neurotrophic factor supporting neuronal survival and neuronal regeneration. Findings of neuropilins as shared co-receptors between molecules with such seemingly different functions as the axon guidance molecules semaphorins and VEGF has further boosted the interest in the role of VEGF in neural tissue injury and repair mechanisms. Thus, VEGF most likely act in parallel or concurrent on cells in both the vascular and nervous system. The present review gives a summary of known or potential aspects of the VEGF system in the healthy and diseased nervous system. The potential benefits but also problems and pitfalls in intervening in the actions of such a multifunctional factor as VEGF in the disordered CNS are also covered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991659     DOI: 10.2174/156720208786413451

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  9 in total

1.  Multiple neurotrophic effects of VEGF on cultured neurons.

Authors:  Alma Sanchez; Suchin Wadhwani; Paula Grammas
Journal:  Neuropeptides       Date:  2010-04-28       Impact factor: 3.286

2.  Regulation of neural stem cell in the human SVZ by trophic and morphogenic factors.

Authors:  Lucia E Alvarez-Palazuelos; Martha S Robles-Cervantes; Gabriel Castillo-Velazquez; Mario Rivas-Souza; Jorge Guzman-Muniz; Norma Moy-Lopez; Rocio E Gonzalez-Castaneda; Sonia Luquin; Oscar Gonzalez-Perez
Journal:  Curr Signal Transduct Ther       Date:  2011-09-01

3.  Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine.

Authors:  Jennifer M Laing; Cynthia C Smith; Laure Aurelian
Journal:  J Neurochem       Date:  2009-11-05       Impact factor: 5.372

4.  Age-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophen.

Authors:  Debjani Tripathy; Alma Sanchez; Xiangling Yin; Joseph Martinez; Paula Grammas
Journal:  Microvasc Res       Date:  2012-08-27       Impact factor: 3.514

5.  Vascular endothelial growth factor regulates adult hippocampal cell proliferation through MEK/ERK- and PI3K/Akt-dependent signaling.

Authors:  Neil M Fournier; Boyoung Lee; Mounira Banasr; Maha Elsayed; Ronald S Duman
Journal:  Neuropharmacology       Date:  2012-05-10       Impact factor: 5.250

6.  Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair?

Authors:  Ana A Baburamani; C Joakim Ek; David W Walker; Margie Castillo-Melendez
Journal:  Front Physiol       Date:  2012-11-09       Impact factor: 4.566

7.  Transplantation of vascular endothelial growth factor-modified neural stem/progenitor cells promotes the recovery of neurological function following hypoxic-ischemic brain damage.

Authors:  Yue Yao; Xiang-Rong Zheng; Shan-Shan Zhang; Xia Wang; Xiao-He Yu; Jie-Lu Tan; Yu-Jia Yang
Journal:  Neural Regen Res       Date:  2016-09       Impact factor: 5.135

8.  Controlled Delivery of Pan-PAD-Inhibitor Cl-Amidine Using Poly(3-Hydroxybutyrate) Microspheres.

Authors:  Dina Ahmed; Hima Puthussery; Pooja Basnett; Jonathan C Knowles; Sigrun Lange; Ipsita Roy
Journal:  Int J Mol Sci       Date:  2021-11-27       Impact factor: 5.923

9.  Short Communication: Interaction of Nerve Growth Factor (NGF) and Vascular Endothelial Growth Factor (VEGF) in Healthy Individuals.

Authors:  Adrian Groh; Kirsten Jahn; Michael Gröschl; Thomas Hillemacher; Johannes Kornhuber; Stefan Bleich; Helge Frieling; Annemarie Heberlein
Journal:  Dis Markers       Date:  2019-11-11       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.